Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Gregory G. Freitag

Board of Directors member
 Biopharmaceutical company 
PDS Biotechnology
United States of America


  Gregory G. Freitag, J.D., CPA, is AxoGen, Inc.’s (NASDAQ: AXGN) General Counsel, SVP of Business Development and a member of its Board of Directors and was its Chief Financial Officer. AxoGen, Inc. is a leading regenerative medicine company dedicated to peripheral nerve repair. Mr. Freitag was Chief Executive Officer, Chief Financial Officer and a board member from June 2010 through September 2011 of LecTec Corporation, an intellectual property licensing and holding company that merged with AxoGen in September 2011. Mr. Freitag is a principal of FreiMc, LLC, a health care and life science consulting and advisory firm he founded that provides strategic guidance and business development services. Prior to founding FreiMc, Mr. Freitag was a Director of Business Development at Pfizer Health Solutions, a former subsidiary of Pfizer, Inc. and worked for Guidant Corporation in their business development group.

Research Interest

 ournal of Molecular Pharmaceutics & Organic Process Research

Global Experts from United States of America

Global Experts in Subject

Share This Profile